Other

Depreciation

Medtronic Depreciation increased by 9.2% to $308.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 14.9%, from $268.00M to $308.00M.

Analysis

StatementIncome Statement
SectionOther
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2025
Last reportedQ3 2026Feb 24, 2026

How to read this metric

High depreciation relative to revenue may indicate a capital-intensive business model or significant recent investment in infrastructure.

Detailed definition

The systematic allocation of the cost of tangible assets over their useful lives. This non-cash expense reflects the wea...

Peer comparison

Standard accounting metric across all capital-intensive industries.

Metric ID: other_depreciation

Historical Data

6 periods
 Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26Q3 '26
Value$248.00M$262.00M$268.00M$289.00M$282.00M$308.00M
QoQ Change+5.6%+2.3%+7.8%-2.4%+9.2%
YoY Change+16.5%+7.6%+14.9%
Range$248.00M$308.00M
CAGR+18.9%
Avg YoY Growth+13.0%
Median YoY Growth+14.9%

Business Segments

View all
SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Diabetes$23.50M$24.00M$27.00M$30.00M$31.00M$31.00M$32.00M$32.00M
Cardiovascular$49.75M$55.00M$56.00M$56.00M$58.00M
Medical Surgical$53.00M
Neuroscience$72.00M
Other operating segment$0.00
Total$248.00M$262.00M$268.00M$289.00M$282.00M$308.00M

Frequently Asked Questions

What is Medtronic's depreciation?
Medtronic (MDT) reported depreciation of $308.00M in Q4 2025.
How has Medtronic's depreciation changed year-over-year?
Medtronic's depreciation increased by 14.9% year-over-year, from $268.00M to $308.00M.
What does depreciation mean?
The annual expense representing the aging and usage of physical assets.